01
Tue, Apr
47 New Articles

The Commission For Protection Of Competition of the Republic of Serbia (“Commission“) recently announced that it will conduct a sectoral analysis of the pharmaceutical industry, specifically examining market conditions and competition in the human drug market in Serbia. This decision comes in light of increasing regulatory oversight and the need to assess competitive conditions in this key sector.

When discussing competition law, the Competition Authority and its powers are usually part of the business conversation, given that it is the key enforcer ensuring fair competition and penalizing those who try to distort it. However, for many undertakings, a decision by the Competition Authority isn’t always the end of their fight for justice – sometimes it’s just the beginning. Affected competitors often have to undertake significant efforts to seek compensation from those whose anti-competitive behaviour has harmed or even destroyed their business. In this article, we share our experience with the first-ever successful follow-on damages action in the Czech Republic and the challenges we encountered along the way.

More Articles ...